ACYCLOVIR RESISTANT MUCOCUTANEOUS HERPES SIMPLEX DISEASE IN AIDS

艾滋病中的阿昔洛韦耐药性皮肤粘膜单纯疱疹病

• 批准号: 3763676
• 负责人: Fred T Valentine
• 金额: --
• 依托单位: NEW YORK UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3763676
• 关键词: AIDS; Herpes simplex disease; antiviral agents; drug resistance; drug screening /evaluation; human subject; human therapy evaluation; medical complication; secondary infection; skin disorder; skin disorder chemotherapy; topical drug application

This open-label pilot study will evaluate the safety, efficacy and toxicity of using topical trifluridine (TFT) in the treatment of acyclovir-resistant mucocutaneous herpes simplex virus (HSV). (ACTG 172)

这项开放标签的初步研究将评估安全性、疗效和 局部使用曲氟尿苷（TFT）治疗 抗阿昔洛韦的皮肤粘膜单纯疱疹病毒（HSV）。(ACTG（172）